News about "Fischer Medical Ventures"

Fischer Medical Ventures to Supply Portable, AI-Powered X-Ray Systems to Indonesia for TB Eradication

Fischer Medical Ventures to Supply Portable, AI-Powered X-Ray Systems to Indonesia for TB Eradication

Fischer Medical Ventures (FMV), through its wholly owned subsidiary Time Medical International Ventures India, has entered into a strategic partnership with Indonesia, in collaboration with PT Pharmindo Rimpang Kokoh (PT Pariko), to support the country’s tuberculosis eradication efforts with advanced portable, AI-enabled X-ray systems.

Fischer Medical Ventures | 01/12/2025 | By Dineshwori

Fischer Medical Ventures Subsidiary Powers Philippines' First Locally-Funded MRI Facility in Bulacan

Fischer Medical Ventures Subsidiary Powers Philippines' First Locally-Funded MRI Facility in Bulacan

The Province of Bulacan has inaugurated the Philippines’ first locally funded Magnetic Resonance Imaging (MRI) facility—developed by Time Medical International Ventures (India), a wholly owned subsidiary of Fischer Medical Ventures.

Fischer Medical Ventures | 24/11/2025 | By Dineshwori 115

Time Medical Launches VEGA, a New Low-Field TOF MRI for Aneurysm Screening

Time Medical Launches VEGA, a New Low-Field TOF MRI for Aneurysm Screening

Time Medical International Ventures, a wholly owned subsidiary of Fischer Medical Ventures, has unveiled VEGA, a heavily optimised permanent-magnet MRI system engineered specifically for rapid, non-contrast TOF angiographic screening of unruptured intracranial aneurysms.

Fischer Medical Ventures | 17/11/2025 | By Dineshwori 139

Fischer Medical Ventures Appoints Dr. Iype Cherian as Director

Fischer Medical Ventures Appoints Dr. Iype Cherian as Director

Fischer Medical Ventures has appointed globally renowned neurosurgeon and innovator Dr. Iype Cherian as Director, strengthening its leadership as the company advances its next-generation intraoperative MRI technology - DRIS–iMRI Medharanya.

Fischer Medical Ventures | 14/11/2025 | By Dineshwori 143

Nanyang Biologics, NVIDIA, HPE and Equinix Collaborate to Build AI Drug Discovery Platform

Nanyang Biologics, NVIDIA, HPE and Equinix Collaborate to Build AI Drug Discovery Platform

Fischer Medical Ventures’ associate company, Nanyang Biologics (NYB), has entered into a strategic collaboration with global technology leaders NVIDIA, Hewlett Packard Enterprise (HPE), and Equinix to build VECURA – an AI-powered drug discovery platform.

Fischer Medical Ventures | 03/09/2025 | By Dineshwori 225


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members